Polycystic Ovary Syndrome (PCOS)

What PCOS Is

Researchers and clinicians diagnose PCOS using the Rotterdam criteria, which require at least two of three features: infrequent or absent ovulation, hyperandrogenism (elevated androgen levels shown clinically or on a blood test), and polycystic ovarian morphology seen on ultrasound.^[3] The framework is built to rule other things out first, since conditions like thyroid disorders can produce a similar picture, and no single feature on its own defines the condition since any one of the three can appear without the other two.^[1]

PCOS is also tied to metabolic changes beyond the reproductive system. Insulin resistance is estimated to affect around 70% of women with PCOS, independent of body weight,^[1] and researchers describe androgen excess and insulin resistance as reinforcing each other: higher insulin is linked to more androgen output from the ovaries, while androgen excess is linked to lower insulin sensitivity.^[1],[4] The World Health Organization notes PCOS carries a longer-term association with insulin resistance, type 2 diabetes, and obesity.^[2]

Why People With PCOS Track These Metrics

Because PCOS is defined by a combination of features that each move on their own timeline, people who have it often log more than one signal instead of relying on any single symptom. Cycle length is one of the more visible ones: researchers define irregularity in this context with specific thresholds, for example fewer than eight cycles a year, or cycle lengths outside 21 to 35 days more than three years past a first period, one of three Rotterdam features researchers assess together rather than a standalone indicator.^[3] A dated cycle-length history is what turns an impression of unpredictable periods into a pattern that's actually measurable. See our irregular periods entry for more on how cycle variability is defined.

Androgen-related changes are the other visible signal, and they often show up as physical symptoms before any lab work happens: hirsutism, coarse hair growth in androgen-sensitive areas, and hormonal acne are both driven by the same androgen pathway.^[1] The lab-based version of that same signal is testosterone, measured as total or free testosterone to check for elevated androgen levels alongside the physical signs.^[3]

Because insulin resistance is so common in PCOS, insulin and related glucose markers are frequently logged alongside cycle and androgen data, since the three systems tend to move together rather than independently.^[1][4] Our PCOS guide goes deeper on how these pieces fit together.

How Go Go Gaia Supports Tracking It

Go Go Gaia logs period dates and cycle length day to day, so a cycle-length pattern builds automatically instead of being reconstructed from memory. Symptom entries for hirsutism, acne, and other androgen-related changes sit on the same timeline, and lab results like testosterone or fasting insulin can be uploaded and charted alongside them. For a closer look at tracking built specifically around PCOS, see our PCOS tracker page.

What the Research Shows

PCOS affects an estimated 10% to 13% of women of reproductive age worldwide by the World Health Organization's estimate, though reported prevalence ranges wider, from about 5% to 26%, depending on which diagnostic criteria a study uses.^[2][1] The WHO also estimates that up to 70% of women with PCOS worldwide are undiagnosed.^[2]

Insulin resistance is estimated to affect around 70% of women with PCOS and operates independently of body weight,^[1] and elevated insulin and elevated androgens are described as reinforcing each other in a self-sustaining cycle.^[1],[4]

The international guideline behind the current Rotterdam-based diagnostic framework also notes that women internationally report delayed diagnosis and dissatisfaction with the diagnostic process, part of the reasoning behind a structured diagnostic algorithm rather than reliance on any single test.^[3]

Related Terms

Frequently Asked Questions

Educational information based on published sources. Not medical advice. For personal concerns, please consult your doctor.

What is PCOS?

Polycystic ovary syndrome is a common hormonal condition defined by some combination of irregular ovulation, elevated androgen levels, and polycystic ovarian morphology on ultrasound. Researchers describe it as the most common endocrine disorder among women of reproductive age worldwide, affecting an estimated 10% to 13% of women by the World Health Organization's estimate.^[1][2]

How do researchers diagnose PCOS?

Clinicians use the Rotterdam criteria, which require at least two of three features: infrequent or absent ovulation, hyperandrogenism shown clinically or on a blood test, and polycystic ovarian morphology on ultrasound, after ruling out other conditions like thyroid disorders that can cause similar symptoms.^[3]

Why is insulin resistance linked to PCOS?

Insulin resistance is estimated to affect around 70% of women with PCOS, independent of body weight.^[1] Researchers describe elevated insulin and elevated androgens as reinforcing each other, since higher insulin is linked to more androgen output from the ovaries while androgen excess is linked to lower insulin sensitivity.^[1],[4]